Specialized Pro-Resolving Mediators in Asthma
哮喘专业解决调解员
基本信息
- 批准号:10625837
- 负责人:
- 金额:$ 73.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-05-20 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAdverse effectsAgonistAllergicAnabolismAnti-Inflammatory AgentsArachidonic AcidsAsthmaBiological ProductsBiopsyCD59 AntigenCell CommunicationCell membraneCellsChronicChronic Obstructive Pulmonary DiseaseDependenceDiseaseDocosahexaenoic AcidsDoseDrug DesignEnzymesEpithelial CellsEpitheliumEssential Fatty AcidsExperimental ModelsFamilyFatty AcidsFundingGene ExpressionGenerationsHeadHealthHomeostasisHumanImmuneIn VitroInflammationInflammatoryInflammatory ResponseKnowledgeLaboratoriesLeukocytesLipidsLipoxinsLungMacrophageMeasuresMediatorModelingModificationMolecularMorbidity - disease rateMusPathway interactionsPharmaceutical PreparationsPlayProcessProductionPublishingPulmonary InflammationRegulationResolutionRespiratory MucosaRoleSeveritiesSignal TransductionSortingStimulusStructure of parenchyma of lungTestingTherapeuticThinkingTissuesTranslationsValidationWorkairway hyperresponsivenessairway inflammationasthma exacerbationasthma modelasthmaticasthmatic airwaycandidate identificationcell typecellular transductioncysteinyl-leukotrienedesigneosinophilexperimental studygranulocytehigh dimensionalityin vivoinsightlipid mediatormolecular imagingmouse modelnovelpre-clinicalpreventprogramsreceptorresponsespatiotemporalstemtranslation to humansvolunteer
项目摘要
Abstract
The proposed experiments will test the hypothesis that specialized pro-resolving mediators (SPMs) and
cysteinyl-containing SPMs (CysSPMs) are produced in the lung to counter-regulate pro-phlogistic responses
and to promote resolution of lung inflammation, in part via activation of a pro-resolving subset of eosinophils.
Although we are accustomed to viewing the increase in airway inflammation and hyper-responsiveness in
asthma as the result of an over-abundance of pro-inflammatory stimuli, the severity and duration of an asthma
exacerbation could also result from insufficient endogenous anti-inflammatory effectors. Cysteinyl leukotrienes
are well appreciated to play pro-phlogistic roles in asthma, but not all lipid mediators initiate inflammation.
There are now several families of specialized pro-resolving mediators (SPM) that have been identified and
characterized in acute inflammation. These protective mediators are enzymatically derived from essential fatty
acids and serve as agonists at specific receptors to transduce cell type specific functional responses, including
in eosinophil subsets that are relevant in asthma. With several drugs already developed to block CysLT
formation or action, the notion that select endogenous lipid-derived mediators are generated to promote
resolution of asthmatic airway responses would turn conventional thinking on its head and identify CysSPMs
as natural pro-resolving mediators and novel templates for drug design.
To test our hypothesis, we propose three specific aims to:
Determine lung SPM and CysSPM production in acute and chronic allergic lung inflammation,
Establish SPM and CysSPM actions in the resolution of lung inflammatory responses, and
Define roles for lung eosinophil subsets in promoting inflammation resolution.
This proposal’s specific aims are directed towards uncovering basic mechanisms that govern the resolution of
allergic airway responses in health and disease.
摘要
拟议的实验将测试的假设,专门的亲解决调解人(SPM)和
含半胱氨酰的SPM(CysSPM)在肺中产生以反调节促炎反应
并且部分地通过激活嗜酸性粒细胞的促消退亚群来促进肺部炎症的消退。
虽然我们习惯于观察气道炎症和高反应性的增加,
哮喘是由于过度的促炎刺激,哮喘的严重程度和持续时间
恶化也可由内源性抗炎效应物不足引起。半胱氨酰白三烯
在哮喘中发挥促炎作用,但并非所有脂质介质都引发炎症。
现在有几个家庭的专门亲解决调解员(SPM)已被确定,
以急性炎症为特征。这些保护介质是酶促衍生自必需脂肪酸,
酸,并作为激动剂在特定的受体,以促进细胞类型的特异性功能反应,包括
与哮喘相关的嗜酸性粒细胞亚群已经开发了几种药物来阻断CysLT
形成或作用的概念,选择内源性脂质衍生的介质产生促进
哮喘气道反应的解析将颠覆传统思维,
作为天然的前拆分介质和药物设计的新模板。
为了验证我们的假设,我们提出了三个具体目标:
确定急性和慢性过敏性肺部炎症中肺SPM和CysSPM的产生,
建立SPM和CysSPM在解决肺部炎症反应中的作用,
明确肺嗜酸性粒细胞亚群在促进炎症消退中的作用。
本提案的具体目标是揭示解决这些问题的基本机制,
健康和疾病中的过敏性气道反应。
项目成果
期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Lipoxin B₄ promotes the resolution of allergic inflammation in the upper and lower airways of mice.
- DOI:10.1038/mi.2014.116
- 发表时间:2015-07
- 期刊:
- 影响因子:8
- 作者:
- 通讯作者:
Cutting edge: maresin-1 engages regulatory T cells to limit type 2 innate lymphoid cell activation and promote resolution of lung inflammation.
- DOI:10.4049/jimmunol.1402534
- 发表时间:2015-02-01
- 期刊:
- 影响因子:0
- 作者:Krishnamoorthy N;Burkett PR;Dalli J;Abdulnour RE;Colas R;Ramon S;Phipps RP;Petasis NA;Kuchroo VK;Serhan CN;Levy BD
- 通讯作者:Levy BD
Mast cells contribute to the resolution of allergic inflammation by releasing resolvin D1.
肥大细胞通过释放 resolvin D1 有助于解决过敏性炎症。
- DOI:10.1016/j.phrs.2023.106691
- 发表时间:2023
- 期刊:
- 影响因子:9.3
- 作者:Puzzovio,PierGiorgio;Pahima,Hadas;George,Tresa;Mankuta,David;Eliashar,Ron;Tiligada,Ekaterini;Levy,BruceD;Levi-Schaffer,Francesca
- 通讯作者:Levi-Schaffer,Francesca
Activation of CD8+ T Cells in Chronic Obstructive Pulmonary Disease Lung.
慢性阻塞性肺疾病肺中 CD8 T 细胞的激活。
- DOI:10.1164/rccm.202305-0924oc
- 发表时间:2023
- 期刊:
- 影响因子:24.7
- 作者:Villaseñor-Altamirano,AnaB;Jain,Dhawal;Jeong,Yunju;Menon,JaivardhanA;Kamiya,Mari;Haider,Hibah;Manandhar,Reshmi;Sheikh,MuhammadDawoodAmir;Athar,Humra;Merriam,LouisT;Ryu,MinHyung;Sasaki,Takanori;Castaldi,PeterJ;Rao,DeepakA
- 通讯作者:Rao,DeepakA
FcεR1-expressing nociceptors trigger allergic airway inflammation.
- DOI:10.1016/j.jaci.2020.12.644
- 发表时间:2021-06
- 期刊:
- 影响因子:14.2
- 作者:Crosson, Theo;Wang, Jo-Chiao;Doyle, Benjamin;Merrison, Hannah;Balood, Mohammad;Parrin, Alexandre;Pascal, Maud;Mindt, Barbara C.;Seehus, Corey R.;Ozcan, Alp;Huang, Xuan;Semenara, Elise;Lai, Nicole Y. Y.;Majdoubi, Abdelilah;Abdulnour, Raja-Elie E.;Rajchgot, Trevor;Rafei, Moutih;Foster, Simmie L.;Thibodeau, Jacques;Fritz, Joerg H.;Levy, Bruce D.;Woolf, Clifford J.;Talbot, Sebastien
- 通讯作者:Talbot, Sebastien
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bruce D Levy其他文献
Clinical problem-solving. Whistling in the dark.
临床问题解决。
- DOI:
10.1056/nejmcps1106363 - 发表时间:
2012 - 期刊:
- 影响因子:0
- 作者:
Daniel A Solomon;Christopher H Fanta;Bruce D Levy;Joseph Loscalzo - 通讯作者:
Joseph Loscalzo
Development of an asthma health-care burden score as a measure of severity and predictor of remission in SARP III and U-BIOPRED: results from two major longitudinal asthma cohorts
开发哮喘保健负担评分作为 SARP III 和 U-BIOPRED 中严重程度的衡量指标和缓解预测因子:来自两个主要纵向哮喘队列的结果
- DOI:
10.1016/s2213-2600(24)00250-9 - 发表时间:
2025-01-01 - 期刊:
- 影响因子:32.800
- 作者:
Joe G Zein;Nazanin Zounemat-Kermani;Ian M Adcock;Bo Hu;Amy Attaway;Mario Castro;Sven-Erik Dahlén;Loren C Denlinger;Serpil C Erzurum;John V Fahy;Benjamin Gaston;Annette T Hastie;Elliot Israel;Nizar N Jarjour;Bruce D Levy;David T Mauger;Wendy Moore;Michael C Peters;Kaharu Sumino;Elizabeth Townsend;Eugene R Bleecker - 通讯作者:
Eugene R Bleecker
Bruce D Levy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bruce D Levy', 18)}}的其他基金
EPHEDRA: Enhanced PHthisic by Environmental Disruptors of Resolution Agonists
麻黄:通过消解激动剂的环境干扰剂增强肺结核
- 批准号:
10662073 - 财政年份:2022
- 资助金额:
$ 73.41万 - 项目类别:
Monitoring pro-resolving leukocyte responses in peripheral blood predicts clinical severity during sepsis
监测外周血中促溶解白细胞反应可预测脓毒症期间的临床严重程度
- 批准号:
10354958 - 财政年份:2022
- 资助金额:
$ 73.41万 - 项目类别:
Monitoring pro-resolving leukocyte responses in peripheral blood predicts clinical severity during sepsis
监测外周血中促溶解白细胞反应可预测脓毒症期间的临床严重程度
- 批准号:
10541851 - 财政年份:2022
- 资助金额:
$ 73.41万 - 项目类别:
Monitoring peripheral blood leukocyte and immune responses in health and disease
监测健康和疾病中的外周血白细胞和免疫反应
- 批准号:
8936128 - 财政年份:2015
- 资助金额:
$ 73.41万 - 项目类别:
Monitoring peripheral blood leukocyte and immune responses in health and disease
监测健康和疾病中的外周血白细胞和免疫反应
- 批准号:
9096011 - 财政年份:2015
- 资助金额:
$ 73.41万 - 项目类别:
Project 2 :Specialized Pro-Resolving Lipid Mediators
项目 2:专业化脂质调节剂
- 批准号:
8449234 - 财政年份:2013
- 资助金额:
$ 73.41万 - 项目类别:
Project 2 :Specialized Pro-Resolving Lipid Mediators
项目 2:专业化脂质调节剂
- 批准号:
8375337 - 财政年份:2012
- 资助金额:
$ 73.41万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 73.41万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 73.41万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 73.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 73.41万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 73.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 73.41万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 73.41万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 73.41万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 73.41万 - 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
- 批准号:
2706416 - 财政年份:2022
- 资助金额:
$ 73.41万 - 项目类别:
Studentship














{{item.name}}会员




